• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconpublic health

public health

Page 54 of 86
Gilead coronavirus trial
NewslettersCan Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
HealthGilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
HealthThe first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
Sanofi CEO Paul Hudson
NewslettersCoronavirus interruption of drug supply chain pushes Sanofi to open a firm in France
By Sy MukherjeeFebruary 24, 2020
Coronavirus science Trump budget
NewslettersWe know something essential about the coronavirus. We’re not doing anything about it
By Clifton LeafFebruary 20, 2020
China coronavirus vaccine smoking men
NewslettersSmoking, coronavirus, and the deaths of Chinese men
By Sy MukherjeeFebruary 19, 2020
China’s high smoking rate may be exacerbating the coronavirus outbreak
HealthChina’s high smoking rate may be exacerbating the coronavirus outbreak
By Sy MukherjeeFebruary 19, 2020
Coronavirus vaccine SARS lessons
HealthSARS treatments could help with the new coronavirus. Why were they shelved?
By Sy MukherjeeFebruary 18, 2020
Coronavirus infections deaths update
NewslettersThe coronavirus picture gets clearer with updated infection, death numbers
By Erika FryFebruary 18, 2020
WWI Helmet Study Duke
NewslettersWhen innovation doesn’t equal improvement
By Sy MukherjeeFebruary 14, 2020
AstraZeneca coronavirus
HealthAstraZeneca stock slips on mixed earnings report and coronavirus uncertainty
By Sy MukherjeeFebruary 14, 2020
In business vs. coronavirus, coronavirus is winning
MagazineIn business vs. coronavirus, coronavirus is winning
By Erika FryFebruary 13, 2020
What health insurance doesn’t cover
NewslettersWhat health insurance doesn’t cover
By Sy MukherjeeFebruary 11, 2020
Coronavirus mask medical supply chain
NewslettersHow coronavirus panic is making virus containment more difficult
By Sy MukherjeeFebruary 7, 2020
Nestle Aimmune Peanut Allergy Drug
NewslettersNestlé invests another $200 million in Aimmune’s peanut allergy drug
By Sy MukherjeeFebruary 5, 2020
1...
  • 52
  • 53
  • 54
  • 55
  • 56
...86
Most Popular
Energy
Analysts expected oil to surge above $200 but China has quietly kept prices half of that—and can’t for much longerplaceholder alt text
By Sasha RogelbergJune 10, 2026
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese militaryplaceholder alt text
By Kate O'Keeffe and BloombergJune 8, 2026
Innovation
Marc Lore’s robots make 500 burrito bowls an hour. A human can make 45placeholder alt text
By Amanda GerutJune 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.